Belite Bio(BLTE) - 2025 Q4 - Earnings Call Presentation

Q4 and FYE 2025 Financial Results Conference Call March 2, 2026, 4:30 p.m. ET Nasdaq: BLTE For more info, please visit: www.belitebio.com Belite Bio Participants Belite Management Team Hao-Yuan Chuang, CFA, MBA, FRM (CFO) B E L I T E B I O / 2 Tom Lin, MMED, PhD, MBA (Chairman, CEO) Hendrik Scholl, MD, MA (CMO) Nathan Mata, PhD (CSO) • 16+ years of executive management roles in biotech • Over 10 new drug developments in multiple therapeutic areas including ophthalmology • University of Sydney, University of ...